-
Pharmaceutical companies raise funds frequently, and most of the funds are used for innovation and research and development
Time of Update: 2022-10-25
In this IPO of the Science and Technology Innovation Board, Baiduoan intends to raise 760 million yuan for medical catheter industrialization upgrade projects, R&D center construction projects, marketing service network and information construction projects, and supplementary working capital projects.
-
Latest! The national mining plan for the spine was finalized, and more than 1.2 million demand broke out
Time of Update: 2022-09-21
Last night (September 7), the Joint Procurement Office of Medical Consumables of the State Organization rushed to the night and issued the "Announcement on the Centralized Procurement of Orthopedic O
-
2022 first quarter performance forecasts have been disclosed one after another, a pharmaceutical company’s revenue and net profit have both surged
Time of Update: 2022-04-15
Kelun Pharmaceutical expects that in the first quarter of 2022, the year-on-year growth rate of net profit attributable to the parent will rebound to 32%, 50%-70%, and the generic drug business will usher in a cash-out period .
-
Turn crises into opportunities and correctly respond to "low oil prices
Time of Update: 2022-03-18
But has the country fully seized the opportunity of "low oil prices" and significantly improved the degree of oil and gas security?
The "low oil price" period is a good opportunity to expand the use of foreign oil and gas resources.
-
The cumulative inflated income is nearly 23.1 billion yuan. Kingenta and "fertilizer
Time of Update: 2022-03-04
Tang Yong, then the manager of the finance department and director of the financial center, participated in the negotiation and was responsible for the specific organization and implementation of Kingenta's fictitious trade business, the transfer of non-operating funds to Nobeifeng, and the false increase in the issuance of goods; participated in the negotiation of false reduction of bills payable; Know or should know the real relationship between Kimenta and Nobel, Furlong, and Notaire .
-
Shandong Chemical Fertilizer Industry: Looking for a new path of transformation and upgrading from manufacturing to service
Time of Update: 2022-02-28
From the production of fertilizers to the provision of full-process nutrition management solutions, many Shandong fertilizer companies have begun to expand the agricultural service market.
-
"Quick charge" and "replacement" lead to controversy, new energy vehicles still need to climb the hurdle
Time of Update: 2021-10-24
In recent years, my country has successively released more than 60 Supporting policies and measures, the development of the new energy automobile industry has achieved positive results, and substantial breakthroughs have been made in basic materials, basic parts, motors, electronic controls, batteries, and complete vehicles.
-
How has it been with the US$74 billion acquisition of Xinji to return to the world's TOP10 BMS
Time of Update: 2021-10-22
With the completion of the acquisition of Xinji by BMS in 2019, the merger of the world's two largest cancer drug companies has given BMS a more significant advantage in the field of tumor immunity .
-
Nervous systemic drug TOP10 came out! Yangzijiang, people's blessings
Time of Update: 2021-01-29
Among them, 1 billion varieties only Yangzijiang Pharmaceutical Group's Zosin injection, while the collection "with fly" hydrochloric acid right metomide injection became the second largest brand; In recent years, the sales of Zosin injections in key provincial and municipal public hospitals (units: 100 million yuan) Source: Minnet key provincial and municipal public hospitals terminal competition pattern Zosin developed by Wyeth-Ayerst Laboratory, adaptive disorders for the need to use opioid analgesics to treat a variety of pain.
-
AJCN: What's new! A balanced intake of carbohydrates and fats may help prevent obesity, diabetes and other metabolic diseases
Time of Update: 2020-10-14
6, 2020 // -- In a recent study published in the international journal The American Journal of Clinical Nutrition, scientists from the Agricultural Research Service of the U.S. Department of Agriculture and others found that high levels of carbohydrate intake may help regulate the expression of specific genes in the body, helping to reduce an individual's risk of obesity, high blood pressure, type 2 diabetes and other metabolic diseases.
-
Entering the window period of annual report, the performance of 100 pharmaceutical and biological enterprises increased in advance or slightly
Time of Update: 2020-02-11
[industry trends of pharmaceutical network] February is the window period of annual report and quarterly report According to data statistics, as of February 7, 2020, 193 pharmaceutical and biological
-
The topic of the 27th March 15th party is almost inseparable
Time of Update: 2018-03-16
Since its launch in 1991, the March 15 party has gone through 27 sessions, and the annual party will become the focus of consumer attention over the years, the March 15 evening exposed a large and
-
The FDA approved eierjian's new schizophrenia drug cariprazine
Time of Update: 2015-09-18
Source: Biovalley 2015-09-18 September 18, 2015, if there is anything that bothers the pharmaceutical developers most, there is no better thing than that the drug can't get the "favor" of relevant pha
-
More than 80% of the annual report of biomedical industry is expected
Time of Update: 2015-01-14
Introduction: the pharmaceutical industry is one of the few industries that are not plagued by the slowdown of economic growth in the two cities Data shows that of 58 pharmaceutical companies that hav
-
Top 12 report 2014: for the first time, the return rate of pharmaceutical R & D ushered in a turning point
Time of Update: 2014-12-11
Source: Biovalley December 11, 2014 Deloitte, one of the four largest accounting firms in the world, recently released a report on the top 12 pharmaceutical giants in the world since 2010 The R & D in
